A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

Clinical trial NCT06203002 · COMPLETED

Trial details

NCT number: NCT06203002
Sponsor: Lexicon Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathic Pain

Start date: 2023-11-29
Primary completion: 2025-01-14
Enrollment: 496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.